Phathom Pharmaceuticals, Inc. (PHAT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 276.57M | 228.97M | 207.78M | 218.88M | 264.9M | 360.13M | 373.82M | 304.79M | 340.31M | 397.43M | 226.73M | 257.72M |
| Cash & Short-Term Investments | 180.9M | 129.97M | 135.16M | 149.57M | 212.31M | 297.26M | 334.68M | 276.24M | 322.23M | 381.39M | 213.68M | 248.85M |
| Cash Only | 180.9M | 129.97M | 135.16M | 149.57M | 212.31M | 297.26M | 334.68M | 276.24M | 322.23M | 381.39M | 213.68M | 248.85M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 80.72M | 78.13M | 55.79M | 51.26M | 36.36M | 38.8M | 21.05M | 10.88M | 3.88M | 1.64M | 0 | 0 |
| Days Sales Outstanding | 122.61 | 106.98 | 99.47 | 100.92 | 118.6 | 92.81 | 89.82 | 91.67 | 131.26 | 220.83 | - | - |
| Inventory | 6.51M | 5.52M | 3.61M | 3.43M | 3.17M | 3.21M | 3.11M | 2.18M | 1.46M | 1.21M | 111K | 111K |
| Days Inventory Outstanding | 45.11 | 54.91 | 52.33 | 59.58 | 77.02 | 76.19 | 103.25 | 120.2 | 284.75 | 172.37 | 84.4 | 82.12 |
| Other Current Assets | 8.44M | 15.35M | 13.23M | 14.62M | 13.05M | 20.87M | 14.98M | 15.5M | 12.75M | 13.19M | 12.94M | 8.76M |
| Total Non-Current Assets | 28.55M | 30.18M | 32.51M | 31.34M | 29.31M | 18.33M | 13.22M | 14.59M | 16.18M | 16.41M | 10.27M | 7.32M |
| Property, Plant & Equipment | 3.52M | 3.67M | 3.85M | 2.12M | 1.74M | 2.09M | 2.49M | 2.86M | 3.23M | 3.62M | 3.66M | 3.04M |
| Fixed Asset Turnover | 16.21x | 15.32x | 16.60x | 20.48x | 14.89x | 12.96x | 6.11x | 2.41x | 0.56x | 0.19x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 2.86M | 2.86M | 2.86M | 2.86M | 2.86M | 2.86M | 2.87M | 0 | 2.86M | 528K |
| Other Non-Current Assets | 25.02M | 26.51M | 25.79M | 26.37M | 24.7M | 13.23M | 7.87M | 8.86M | 10.09M | 12.79M | 3.75M | 3.75M |
| Total Assets | 305.12M | 259.15M | 240.29M | 250.22M | 294.21M | 378.47M | 387.04M | 319.38M | 356.5M | 413.84M | 236.99M | 265.04M |
| Asset Turnover | 0.21x | 0.23x | 0.20x | 0.15x | 0.08x | 0.08x | 0.05x | 0.02x | 0.00x | 0.00x | - | - |
| Asset Growth % | 3.71% | -31.53% | -37.92% | -21.65% | -17.47% | -8.55% | 63.32% | 20.5% | 147.55% | 151.1% | 17.36% | 24.14% |
| Total Current Liabilities | 125.04M | 132.04M | 93.12M | 91.82M | 74.03M | 85.73M | 65.29M | 47.01M | 43.46M | 38.78M | 23.98M | 21.55M |
| Accounts Payable | 6.37M | 4.98M | 1.07M | 4.01M | 11.62M | 10.51M | 7.13M | 7.66M | 8.4M | 12.6M | 5.79M | 4.17M |
| Days Payables Outstanding | 42.57 | 36.44 | 37.77 | 141.12 | 267.34 | 212.7 | 288.75 | 531.02 | 2.24K | 2.4K | 3.79K | 3.29K |
| Short-Term Debt | 667K | 648K | 591K | 21.76M | 17.27M | 20.28M | 20.87M | 9.91M | 16.48M | 0 | 3.11M | 993K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 118.01M | 126.41M | 91.46M | 47.11M | 0 | 38.28M | 23.1M | 0 | 0 | 20.43M | 7.77M | 9.85M |
| Current Ratio | 2.21x | 1.73x | 2.23x | 2.38x | 3.58x | 4.20x | 5.73x | 6.48x | 7.83x | 10.25x | 9.46x | 11.96x |
| Quick Ratio | 2.16x | 1.69x | 2.19x | 2.35x | 3.54x | 4.16x | 5.68x | 6.44x | 7.80x | 10.22x | 9.45x | 11.96x |
| Cash Conversion Cycle | 125.16 | 125.45 | 114.03 | 19.39 | -71.72 | -43.7 | -95.68 | -319.15 | -1.83K | -2.01K | - | - |
| Total Non-Current Liabilities | 517.03M | 565.27M | 569.7M | 564.23M | 558.55M | 546.32M | 508.87M | 506.2M | 461.54M | 447.82M | 230.79M | 225.89M |
| Long-Term Debt | 1.96M | 2.06M | 2.12M | 552.14M | 547.05M | 534.67M | 498.12M | 495.61M | 451.55M | 137.84M | 222.66M | 217.6M |
| Capital Lease Obligations | 0 | 0 | 0 | 589K | 0 | 0 | 0 | 133K | 292K | 462K | 628K | 789K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 150K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 515.07M | 563.21M | 567.58M | 11.5M | 11.5M | 11.5M | 10.75M | 10.45M | 9.7M | 309.52M | 7.5M | 7.5M |
| Total Liabilities | 642.08M | 697.32M | 662.82M | 656.05M | 632.58M | 632.05M | 574.16M | 553.21M | 505M | 486.6M | 254.76M | 247.44M |
| Total Debt | 2.63M | 2.71M | 2.71M | 574.5M | 564.64M | 554.95M | 518.99M | 506.38M | 469.05M | 139.03M | 226.4M | 219.39M |
| Net Debt | -178.28M | -127.26M | -132.44M | 424.93M | 352.32M | 257.69M | 184.31M | 230.14M | 146.82M | -242.36M | 12.72M | -29.46M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | 12.47x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -0.98x | -0.36x | -0.95x | -3.42x | -4.36x | -3.00x | -3.63x | -4.15x | -3.83x | -5.11x | -3.28x | -3.26x |
| Total Equity | -336.95M | -438.17M | -422.53M | -405.83M | -338.38M | -253.58M | -187.11M | -233.83M | -148.5M | -72.76M | -17.77M | 17.6M |
| Equity Growth % | 0.42% | -72.79% | -125.82% | -73.56% | -127.86% | -248.52% | -952.79% | -1428.57% | -64.65% | 2.75% | 32.74% | 351.43% |
| Book Value per Share | -4.11 | -5.94 | -5.76 | -5.60 | -4.70 | -3.57 | -2.90 | -3.99 | -2.54 | -1.27 | -0.31 | 0.36 |
| Total Shareholders' Equity | -336.95M | -438.17M | -422.53M | -405.83M | -338.38M | -253.58M | -187.11M | -233.83M | -148.5M | -72.76M | -17.77M | 17.6M |
| Common Stock | 7K | 6K | 6K | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 5K | 5K |
| Retained Earnings | -1.51B | -1.48B | -1.46B | -1.43B | -1.36B | -1.26B | -1.19B | -1.1B | -1.01B | -928.68M | -849.12M | -805.87M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |